SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001711279-24-000013
Filing Date
2024-04-04
Accepted
2024-04-04 16:08:26
Documents
19
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A krys-20240403.htm   iXBRL DEF 14A 892118
6 krys-20240403_g1.jpg GRAPHIC 52753
7 krys-20240403_g2.jpg GRAPHIC 185999
8 krys-20240403_g3.jpg GRAPHIC 127932
9 krys-20240403_g4.jpg GRAPHIC 439037
10 krys-20240403_g5.jpg GRAPHIC 186382
  Complete submission text file 0001711279-24-000013.txt   3845061

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20240403.xsd EX-101.SCH 4307
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20240403_def.xml EX-101.DEF 5670
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20240403_lab.xml EX-101.LAB 8440
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20240403_pre.xml EX-101.PRE 5282
22 EXTRACTED XBRL INSTANCE DOCUMENT krys-20240403_htm.xml XML 182593
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38210 | Film No.: 24823210
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)